Abstract
Status epilepticus (SE) is a life-threatening medical emergency that requires prompt recognition and treatment. SE is not a specific disease but is a manifestation of either a primary central nervous system (CNS) insult, or a systemic disorder with secondary CNS effects. It is mandatory to look for an underlying cause, especially in younger children and infants, in whom symptomatic SE is more common. Identifying and treating the precipitating cause helps control seizures, prevents ongoing neurologic injury, and hopefully prevents seizure recurrence. Basic neuroresuscitation principles, the ABCs (airway, breathing, circulation), are the cornerstone of initial treatment. An organized and systematic treatment regimen, planned in advance, is needed, including one for refractory status epilepticus (RSE). Initial treatment follows the ABCs but, once stabilized, patient management may be individualized.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Riviello JJ. Status epilepticus. In: Wyllie E, ed. The Treatment of Epilepsy: Principles and Practice 4th ed. Baltimore: Williams & Wilkins; (in press).
Gastaut H. Classification of status epilepicus. Adv Neurol 1983;34:15–35.
Aicardi J, Chevrie JJ. Convulsive status epilepticus in infants and children: a study of 239 cases. Epilepsia 1970;11:187–197.
Working Group on Status Epilepticus, Epilepsy Foundation of America. Treatment of convulsive status epilepticus. JAMA 1993;270:854–859.
Proposal for revised classification of epilepsies and epileptic syndromes. Epilepsia 1989;30:389–399.
Treiman DM, Delgado-Escueda AV. Status epilepticus. In: Thompson RA, Green RA, Green JR, eds. Critical Care of Neurological and Neurosurgical Emergenices. New York: Raven Press; 1980;53–99.
Sahin M, Menache C, Holmes GL, Riviello JJ. Outcome of severe refractory status epilepticus in children. Epilepsia 2001;42:1461–1467.
Treiman DM, DeGiorgio CM, Salisbury S, Wickboldt C. Subtle generalized convulsive status epilepticus. Epilepsia 1984;25:653 (abstract).
Pakalnis A, Paolicchi J, Gilles E. Psychogenic status epilepticus in children: psychiatric and other risk factors. Neurology 2000;54:969–970.
Tuxhorn IEB, Fischbach HS. Pseudostatus epilepticus in childhood Pediatr Neurol 2002;27:407–409.
Shorvon S. Status Epilepticus: Its Clinical Features and Treatment in Children and Adults. Cambridge: Cambridge University Press; 1994.
Riviello JJ. Pediatric status epilepticus. Ann Em Med (in press).
Treiman DM, Walton NY, Kendrick C. A progressive sequence of electroencephalographic changes during generalized convulsive status epilepticus. Epilepsy Res 1990;5:49–60.
Lowenstein DH, Aminoff MJ. Clinical and EEG features of status epilepticus in comatose patients. Neurology 1992;42:100–104.
Garzon E, Fernandes RM, Sakamoto AC. Serial EEG during human status epilepticus: evidence for PLED as an ictal pattern. Neurology 2001;57:1175–1183.
Morton LD, Leszczyszyn DJ, Kopec-Garnett L, Towne AR, Waterhouse EJ, Pellock JM, DeLorenzo RJ. Maturational changes in the EEG of status epilepticus in the first six months of life. Neurology 2000;54(suppl 3);248 (abstract).
Treiman DM, Meyers PD, Walton NY, Collins JF, Colling C, Rowan AJ, Handforth A, Faught E, Calabrese VP, Uthman BM, Ramsay RE, Mamdani MB. A comparison of four treatments for generalized convulsive status epilepticus. N Eng J Med 1998;339:792–798.
Lowenstein DH, Bleck T, Macdonald RL. It’s time to revise the definition of status epilepticus. Epilepsia 1999;40:120–122.
Alldredge BK, Gelb AM, Isaacs SM, Corry MD, Allen F, Ulrich S, Gottwald MD, O’Neil N, Neuhaus JM, Segal MR, Lowenstein DH. A comparison of lorazepam, diazepam, and placebo for the treatment of out-of-hospital status epilepticus. N Engl J Med 2001;345:631–637.
Shinnar S, Berg AT, Moshe SL, Shinnar R. How long do new-onset seizures in children last? Ann Neurol 2001;49:659–664.
Mayer SA, Claassen J, Lokin J, Mendelsohn F, Dennis LJ, Fitzsimmons B-F. Refractory status epileptcius: Frequency, risk factors, and impact on outcome. Arch Neurol 2002;59:205–210.
Mazarati AM, Baldwin RA, Sankar R, Wasterlain CG. Time-dependent decrease in the effectiveness of antiepileptic drugs during the course of self-sustaining status epilepticus. Brain Res 1998;814:179–185.
Kapur J, Lothman EW, DeLorenzo RJ. Loss of GABAA receptors during partial status epilepticus. Neurology 1994;44:2407–2408.
Kapur J, Macdonal RL. Rapid seizure-induced reduction of benzodiazepine and Zn2+ sensitivity of hippocampal dentate granule cell GABA-A receptors J Neurosci 1997;17:7532–7540.
Jones DM, Esmaeil N, Maren S, Macdonald RL Characterization of pharmacoresistance to benzodiazepines in the rat Li-pilocarpine model of status epielpticus. Epilepsy Res 2002;50:301–312.
Goodkin HP, Liu X, Holmes GL. Diazepam terminates brief but not prolonged seizures in young, naïve rats. Epilepsia 2003;44:1109–1112.
De Lorenzo RJ, Pellock JM, Towne AR, Boggs JG. Epidemiology of status epilepticus. Clin Neurophysiol 1995;12:316–325.
DeLorenzo RJ, Hauser WA, Towne AR, Boggs JG, Pelock JM, Penberthy L, Garnett L, Fortner CA, Ko D. A prospective, population-based epidemiologic study of status epilepticus in Richmond, Virginia. Neurology 1996;46:1029–1035.
Hesdorffer DC, Logroscino G, Cascino G, Annegers JF, Hauser WA. Incidence of status epilepticus in Rochester, Minnesota, 1965–1984. Neurology 1998;50:735–741.
Coeytaux A, Jallon P, Galobardes B, Morabia A. Incidence of status epilepticus in French-speaking Switzerland (EPISTAR). Neurology 2000;55:693–697.
Wu YW, Shek DW, Garcia PA, Zhao S, Johnston SC. Incidence and mortality of generalized convulsive status epilepticus in California. Neurology 2002;58:1070–1076.
Berg AT, Shinnar S, Levy SR, Testa FM. Status epilepticus in children with newly diagnosed epilepsy. Ann Neurol 1999;45:618–623.
Sillanpaa M, Shinnar S. Status epilepticus in a population-based cohort with childhood-onset epilepsy in Finland. Ann Neurol 2002;52:303–310.
Shinnar S, Pellock JM, Moshe SL, Maytal J, O’Dell C, Driscoll SM, Alemany M, Newstein D, DeLorenzo RJ. In whom does status epilepticus occur: age-related differences in children. Epilepsia 1997;38:907–914.
Shinnar S, Maytal J, Krasnoff L, Moshe SL. Recurrent status epilepticus in children. Ann Neurol 1992;31:598–604.
Maytal J, Shinnar S, Moshe SL, Alvarez LA. Low morbidity and mortality of status epilepticus in childhood. Pediatrics 1989;83:323–331.
DeLorenzo RJ, Towne AR, Pellock JM, Ko D. Status epilepticus in children, adults, and the elderly. Epilepsia 1992;33(suppl 4):15–25.
Morton LD, Garnett LK, Towne AR, Waterhouse EJ, Brown AJ, Byers SF, Pellock JM, DeLorenzo RJ. Mortality of status epilepticus in the first year of life. Epilepsia 2001;42(suppl 7):164–165.
Bui TT, Delgado CA, Simon HK. Infant seizures not so infantile: first-time seizures in children under six months of age presenting to the ED. Am J Emerg Med 2002;20:518–520.
Fujiwara T, Ishida S, Miyakoshi M, Sakuma N, Moriyama S, Morikawa T, Seino M, Wada T. Status epilepticus in childhood: A retrospective study of initial convulsive status and subsequent epilepsies. Folia Psychiatrica et Neurologica Japonica 1979;33:337–344.
Vigevano F, DiPapua M, Fusco L, Bertini E, Maccagnani F. Status epilepticus in infancy and childhood. J Ped Neurosci 1985;1:101–112.
Dunn DW. Status epilepticus in children: Etiology, clinical features, and outcome. J Child Neurol 1988:3:167–173.
Yager JY, Cheang M, Seshia SS. Status epilepticus in childhood. Can J Neurol Sci 1988;15:402–405.
Phillips SA and Shanahan RJ. Etiology and mortality of status epilepticus in children: A recent update. Arch Neurol 1989;46:74–76.
Lacroix J, Deal C, Gauthier M, Rousseau E, Farrell CA. Admissions to a pediatric intensive care unit for status epilepticus: a 10-year experience. Crit Care Med 1994;22:827–832.
Mah JK, Mah MW Pediatric status epilepticus: a perspective from Saudi Arabia. Pediatr Neurol 1999;20:364–369.
Barnard C, Wirrell E. Does status epilepticus in children cause developmental deterioration and exacerbation of epilepsy? J Child Neurol 1999;14:787–794.
Barry E, Hauser WA. Status epilepticus: the interaction of epilepsy and acute brain disease. Neurology 1993;43:1473–1478.
Krumholz A, Sung GY, Fisher RS, Barry E, Bergey GK, Gratton LM. Complex partial status epilepticus accompanied by serious morbidity and mortality. Neurology 1995;45:1499–1504.
Krumholz A. Epidemiology and evidence for morbidity of nonconvulsive status epilepticus. J Clin Neurophysiol 1999;16:314–322.
Drislane FW. Evidence against permanent neurologic damage from nonconvulsive status epilepticus. J Clin Neurophysiol 1999;16:323–331.
Nelson KB, Ellenberg JH. Prognosis in children with febrile seizures. Pediatrics 1978;61:720–727.
Viani F, Beghi E, Romeo A, van Lierde A. Infantile febrile status epilepticus: risk factors and outcome. Dev Med Child Neurol 1987;29:495–501.
Van Esch A, Ramlal IR, van Steensel-Moll HA, Steyerberg EW, Derksen-Lubsen G. Outcome after febrile status epilepticus. Dev Med Child Neurol 1996;38:19–24.
Maytal J, Shinnar S. Febrile status epilepticus. Pediatrics 1990;86:611–616.
Verity CM, Ross EM, Golding J. Outcome of childhood status epilepticus and lengthy febrile convulsions: findings of national cohort study. BMJ 1993;307:225–228.
Scholtes FB, Renier WO, Meinardi H. Generalized convulsive status epilepticus: causes, therapy, and outcome in 346 patients. Epilepsia 1994;35:1104–1112.
Schmidley JW, Simon RP. Postictal pleocytosis. Ann Neurol 1981;9:81–84.
Barry E, Hauser WA. Pleocytosis after status epilepticus. Arch Neurol 1994;51:190–193.
Maytal J, Novak G, Ascher C, Bienkowski R. Status epilepticus in children with epilepsy: the role of antiepileptic drug levels in prevention. Pediatrics 1996;98:1119–1121.
Caksen H, Odabas D, Erol M, Anlar O, Tuncer O, Atas B. Do not overlook acute isoniazid poisoning in children with status epilepticus. J Child Neurol 2003;18:142–143.
Hankins DG, Saxena K, Faville RJ Jr, Warren BJ. Profound acidosis caused by isoniazid ingestion. Am J Emerg Med 1987;5:165–166.
Haverkos GP, DiSalvo RP, Imhoff TE. Fatal seizures after flumazenil administration in a patient with a mixed overdose. Ann Pharmacother 1994;28:1347–1349.
Practice parameter: Neuroimaging in the emergency patient presenting with seizure. Ann Emerg Med 1996;27:114–118.
Sharma S, Riviello JJ, Harper MB, Baskin MN. The role of emergent neuroimaging in children with new-onset afebrile seizures. Pediatrics 2003:111:1–5.
Privitera MD, Strawsurg RH. Electroencephalographic monitoring in the emergency department. Emerg Med Clinics N Amer 1994;12:1089–1101.
DeLorenzo RJ, Waterhouse EJ, Towne AR, Boggs JG, Ko D, DeLorenzo GA, Brown A, Garnett L. Persistent nonconvulsive status epilepticus after the control of generalized convulsive status epilepticus. Epilepsia 1998;39:833–840.
Towne AR, Waterhouse EJ, Boggs JG, Garnett LK, Brown AJ, Smith JR Jr, DeLorenzo RJ. Prevalence of nonconvuslive status epilepticus in comatose patients. Neurology 2000;54:340–345.
Thomas P. Status epileptics: Indications for emergency EEG. Neurophysiol Clin 1997;27:398–405.
Lothman E. The biochemical basis and pathophysiology of status epilepticus Neurology 1990;40(suppl 2):13–23.
Wijdicks EF, Hubmayr RD. Acute acid-base disorders associated with status epilepticus. Mayo Clin Proc 1994;69:1044–1046.
DeGiorgio CM, Correale JD, Gott PS, Ginsburg DL, Bracht KA, Smith T, Boutros R, Loskota WJ, Rabinowicz AL. Serum neuron-specific enolase in human status epilepticus. Neurology 1995;45:1134–1137.
Rabinowicz AL, Correale JD, Bracht KA, Smith TD, DeGiorgio CM. Neuron-specific enolase in increased after nonconvulsive status epilepticus. Epilepsia 1995;36:475–479.
Browne TR. The pharmacokinetics of agents used to treat status epilepticus. Neurology 1990;40(suppl 2);28–32.
Prensky AL, Raff MC, Moore MJ, Schwab RS Intravenous diazepam in the treatment of prolonged seizure activity N Eng J Med 1967;276:779–784.
Sawyer GT, Webster DD, Schut LL. Treatment of uncontrolled seizure activity with diazepam. JAMA 1968;203:913–918.
Treiman DM. The role of benzodiazepines in the management of status epilepticus. Neurology 1990;40(suppl 2);32–42.
Cock HR, Schapira AH. A comparison of lorazepam and diazepam as initial therapy in convulsive status epilepticus. Q J Med 2002;95:225–231.
Walker JE, Homan RW, Vasko MR, Crawford IL, Bell RD, Tasker WG. Lorazepam in status epilepticus. Ann Neurol 1979;6:207–213.
Lacey DJ, Singer WD, Horwitz SJ, Gilmore H. Lorazepam therapy of status epilepticus in children and adolescents. J Pediatr 1986;108:771–774.
Crawford TO, Mitchell WG, Snodgrass SR. Lorazepam in childhood status epilepticus and serial seizures: effectiveness and tachyphylaxis. Neurology 1987;37:190–195.
Leppik IE, Derivan AT, Homan RW, Walker J, Ramsay RE, Patrick B. Double-blind study of lorazepam and diazepam in status epilepticus. JAMA 1983;249:1452–1454.
Kumar A, Bleck TP. Intravenous midazolam for the treatment of refractory status epilepticus. Crit Care Med 1992;20:483–488.
Cranford RE, Leppik IE, Patrick B, Anderson CB, Kostick B. Intravenous phenytoin: clinical and pharmacokinetic aspects. Neurology 1978;28:874–880.
Cloyd JC, Gumnit RJ, McLain LW Jr. Status epilepticus. The role of intravenous phenytoin. JAMA 1980;244:1479–1491.
Salem RB, Wilder BJ, Yost RL, Doering PL, Lee C. Rapid infusion of phenytoin sodium loading doses. Am J Hosp Pharm 1981;38:354–357.
Riviello JJ, Roe EJ, Sapin JI, Grover WD. Timing of maintenance phenytoin therapy after an intravenous loading dose. Pediatr Neurol 1991;7:262–265.
O’Brien TJ, Cascino GD, So EL, Hanna DR. Incidence and clinical significance of the purple glove syndrome in patients receiving intravenous phenytoin. Neurology 1998;51:1034–1039.
Burneo JG, Anandan JV, Barkley GL. A prospective study of the incidence of purple glove syndrome. Epilepsia 2001;42:1156–1159.
Yoshikawa H, Abe T, Oda Y. Purple glove syndrome caused by oral administration of phenytoin. J Child Neurol 2000;15:762.
Browne TR. Fosphneytoin (Cerebyx). Clin Neuropharmacol 1997;20:1–12.
Fischer JH, Patel TV, Fischer PA. Fosphenytoin: clinical pharmacokinetics and comparative advantages in the acute treatment of seizures. Clin Pharmacokinet 2003:42:33–58.
Takeoka M, Krishnamoorthy KS, Soman TB, Caviness VS. Fosphenytoin in infants. J Child Neurol 1998;13:537–540.
Koul R, Deleu D. Subtherapeutic free phenytoin levels following fosphenytoin therapy in status epilepticus. Neurology 2002;58:147–148.
Painter MJ, Scher MS, Stein AD, Armatti S, Wang Z, Gardiner JC, Paneth N, Minnigh B, Alvin J. Phenobarbital compared with phenytoin for the treatment of neonatal seizures. N Engl J Med 1999;341:485–489.
Shaner DM, McCurdy SA, Herring MO, Gabor AJ. Treatment of status epilepticus: a prospective comparison of diazepam and phenytoin vs phenobarbital and optional phenytoin. Neurology 1988;38:202–207.
Holmes GL. Phenobarbital dose for status epilepticus. Am J Hosp Pharm 1994;51:1578.
Devinsky O, Leppik I, Willmore LJ, Pellock JM, Dean C, Gates J, Ramsay RE, the Intravenous Valproate Study Team. Safety of intravenous valproate. Ann Neurol 1995;38:670–674.
Campistol J, Fernandez A, Ortega J. Status epilepticus in children. Experience with intravenous valproate. Rev Neurol 1999;29:359–365.
Hovinga CA, Chicella MF, Rose DF, Eades SK, Dalton JT, Phelps SJ. Use of intravenous valproate in three pediatric patients with nonconvulsive status epilepticus. Ann Pharmacother 1999;33:579–584.
Venkataraman V, Wheless JW. Safety of rapid intravenous infusion of valproate loading doses in epilepsy patients. Epilepsy Res 1999;35:147–153.
Yu KT, Mills S, Thompson N, Cunanan C. Safety and efficacy of intravenous valproate in pediatric status epilepticus and acute repetitive seizures. Epilepsia 2003;44:724–726.
White JR, Santos CS. Intravenous valproate associated with significant hypotension in the treatment of status epilepticus. J Child Neurol 1999;14:822–823.
Alfonso I, Alvarez LA, Gilman J, Dunoyer C, Yelin K, Papazian O. Intravenous valproate dosing in neonates. J Child Neurol 2000;15:827–829.
Shephard SM. Management of status epilepticus. Emerg Med Clin North Am 1994;12:941–961.
Appleton R, Choonara I, Martland T, Phillips B, Scott R, Whitehouse W. The Status Epilepticus Working Party. The treatment of convulsive status epilepticus in children. Arch Dis Child 2000;83:415–419.
Walker MC, Smith SJ, Shorvon SD. The intensive care treatment of status epilepticus in the UK. Results of a national survey and recommendations. Anaesthesia 1995;50:130–135.
Delanty N, French JA, Labar DR, Pedley TA, Rowan AJ. Status epilepticus arising de novo in hospitalized patients: an analysis of 41 patients. Seizure 2001;10:116–119.
Cornfield DN, Tegtmeyer K, Nelson MD, Milla CE, Sweeney M. Continuous propofol infusion in 142 critically ill children. Pediatrics 2002;110:1177–1181.
Code Team Manual. Children’s Hospital, Boston, 2003.
Erikkson KJ, Koivikko MJ. Status epilepticus in children: aetiology, treatment and outcome. Dev Med Child Neurol 1997;39:652–658.
Garr RE, Appleton RE, Robson WJ, Molyneux EM. Children presenting with convulsions (including status epilepticus) to a paediatric accident and emergency department: an audit of a treatment protocol. Dev Med Child Neurol 1999;41:44–47.
Claassen J, Hirsch LJ, Mayer SA. Treatment of status epilepticus: a survey of neurologists. J Neurol Sci 2003;211:37–41.
Karceski S, Morrell M, Carpenter D. The expert consensus guideline series: treatment of epilepsy. Epilepsy Behav 2001;2(suppl)A1–50.
Appleton R, Martland T, Phillips B. Drug management for acute tonic-clonic convulsions ncluding convulsive status epilepticus in children. Cochrane Database Syst Rev 2002:CD001905.
Qureshi A, Wassmer E, Davies P, Berry K, Whitehouse WP. Comparative audit of intravenous lorazepam and diazepam in the emergency treatment of convulsive status epilepticus in children. Seizure 2002;11:141–144.
Gilbert DL, Gartside PS, Glauser TA. Efficacy and mortality in treatment of refractory generalized convulsive status epilepticus in children: a meta-analysis. J Child Neurol 1999;14:602–609.
Kim SJ, Lee DY, Kim JS. Neurologic outcomes of pediatric patients treated with pentobarbital coma. Pediatr Neurol 2001;25:217–220.
Young GB, Blume WT, Bolton CF, Warren KG. Anesthetic barbiturates in refractory status epilepticus. Can J Neurol Sci 1980;7:291–292.
van Ness PC. Pentobarbital and EEG burst suppression in treatment of status epilepticus refractory to benzodiazepines and phenytoin. Epilepsia 1990;31:61–67.
Young RS, Ropper AH, Hawkes D, Woods M, Yohn P. Pentobarbital in refractory status epilepticus. Pediatr Pharmacol 1983;3:63–67.
Rashkin MC, Youngs C, Penovich P. Pentobarbital treatment of refractory status epilepticus. Neurology 1987;37:500–503.
Lowenstein DH, Aminoff MJ, Simon RP. Barbiturate anesthesia in the treatment of status epilepticus: clinical experience with 14 patients. Neurology. 1988;38:395–400.
Osorio I, Reed RC. Treatment of refractory generalized tonic-clonic status epilepticus with pentobarbital anesthesia after high-dose phenytoin. Epilepsia 1989;30:464–471.
Yaffe K, Lowenstein DH. Prognostic factors of pentobarbital therapy for refractory generalized status epilepticus. Neurology 1993;43:895–900.
Rivera R, Segnini M, Baltodano A, Perez V. Midazolam in the treatment of status epilepticus in children. Crit Care Med 1993;21:991–994.
Parent JM, Lowenstein DH. Treatment of refractory generalized status epilepticus with continuous infusion of midazolam. Neurology 1994;44:1837–1840.
Holmes GL, Riviello JJ Jr. Midazolam and pentobarbital for refractory status epilepticus. Pediatr Neurol 1999;20:259–264.
Prasad A, Worrall BB, Bertram EH, Bleck TP. Propofol and midazolam in the treatment of refractory status epilepticus. Epilepsia 2001;42:380–386.
Claassen J, Hirsch LJ, Emerson RG, Bates JE, Thompson TB, Mayer SA. Continuous EEG monitoring and midazolam infusion for refractory nonconvulsive status epilepticus. Neurology 2001;57:1036–1042.
Hamano S, Tanaka M, Mochizuki M, Sugiyama N, Eto Y. Midazolam treatment for status epilepticus in children. No To Hattatsu 2003;35:304–309.
Minagawa K, Watanabe T. Eight-year study on the treatment with midazolam for status epilepticus and clusters of seizures in children. No To Hattatsu 2003;35:484–490.
Crawford TO, Mitchell WG, Fishman LS, Snodgrass SR. Very high dose phenobarbital for refractory status epilepticus in children. Neurology 1988;38:1035–1040.
Sudoh A, Sugai K, Miyamoto T, Mimaki M, Fukumizu M, Hanaoka S, Sasaki M. Non-intravenous high-dose phenobarbital therapy for status epilepticus refractory to continuous infusion of midazolam or pentobarbital: report of three cases. No To Hattatsu 2002;34:23–29.
Singhi S, Banerjee S, Singhi P. Refractory status epileptics in children: role of continuous diazepam infusion. J Child Neurol 1998;13:23–26.
Singhi S, Murthy A, Singhi P, Jayashree M. Continuous midazolam vs diazepam infusion for refractory convulsive status epilepticus. J Child Neurol 2002;17:106–110.
Labar DR, Ali A, Root J. High-dose intravenous lorazepam for the treatment of refractory status epilepticus. Neurology 1994;44:1400–1403.
Parviainen I, Uusaro A, Kalviainen R, Kaukanen E, Mervaala E, Ruokonen E. High-dose thiopental in the treatment of refractory status epilepticus in the intensive care unit. Neurology 2002;59:1249–1251.
De Giorgio CM, Altman K, Hamilton-Byrd E, Rabinowicz AL. Lidocaine in refractory status epilepticus: confirmation of efficacy with continuous EEG monitoring. Epilepsia 1992;33:913–916.
Pascual J, Ciudad J, Berciano J. Role of lidocaine (lignocaine) in managing status epilepticus. J Neurol Neurosurg Psychiatry 1992;55:49–51.
Sata Y, Aihara M, Hatakeyama K, Hinohara Y, Kamiya Y, Shimoda C, Kanemura H, Nakazawa S. Efficacy and side effects of lidocaine by intravenous drip infusion in children with intractable seizures. No To Hattatsu 1997;29:39–44.
Tanabe T, Suzuki S, Shimakawa S, Yamashiro K, Tamai H. Problems of intravenous lidocaine treatment in status epilepticus or clustering seizures in childhood. No To Hattatsu 1999;31:14–20.
Kofke WA, Snider MT, Young RSK, Ramer JC. Prolonged low flow isoflurane anesthesia for status epilepticus. Anesthesiology 1985;62:653–656.
Roper AH, Kofke WA, Bromfield EB, Kennedy SK. Comparison of isoflurane, halothane, and nitrous oxide in status epilepticus. Ann Neurol 1986;19:98–99.
Stecker MM, Kramer TH, Raps EC, O’Meeghan R, Dulaney E, Skaar DJ. Treatment of refractory status epilepticus with propofol: clinical and pharmacokinetic findings. Epilepsia 1998;39:18–26.
Parke TJ, Stevens JE, Rice ASC, Greenaway CL, Bray RJ, Smith PJ, Waldmann CS, Verghese C. Metabolic acidosis and fatal myocardial failure after propofol infusion in children: five case reports. BMJ 1992;305:613–616.
Hanna JP, Ramundo ML. Rhabdomyolysis and hypoxia associated with prolonged propofol infusion in children. Neurology 1998;50:301–303.
Stelow EB, Johari VP, Smith SA, Crosson JT, Apple FS. Propofol-associated rhabdomyolysis with cardiac involvement in adults. Clin Chemistry 2000;46:577–581.
Vasile B, Rasulo F, Candiani A, Latronico N. The pathophysiology of propofol infusion syndrome: a simple name for a complex syndrome. Int Care Med 2003;29:1417–1425.
Fujikawa DG. Neuroprotective effect of ketamine administered after status epilepticus onset. Epilepsia 1995;36:186–195.
Borris DJ, Bertram EH, Kapur J. Ketamine controls prolonged status epilepticus. Epilepsy Res 2000;42:117–122.
Sheth RD, Gidal BE. Refractory status epilepticus: response to ketamine. Neurology 1998;51:1765–1766.
Browne TR. Paraldehyde, chlormethiazole, and lidocaine for status epilepticus. Adv Neurol 1983;34:509–517.
Yeoman P, Hutchinson A, Byrne A, Smith J, Durham S. Etomidate infusions for the control of refractory status epilepticus. Int Care Med 1989;15:255–259.
Congdon PJ, Forsythe WI. Intravenous clonazepam in the treatment of status epilepticus in children. Epilepsia 1980;21:97–102.
Curless RG, Holzman BH, Ramsay RE. Paraldehyde therapy in childhood status epilepticus. Arch Neurol 1983;40:477–480.
Lampl Y, Eshel Y, Gilad R, Sarova-Pinchas I. Chloral hydrate in intractable status epilepticus. Ann Emerg Med 1990;19:674–676.
Orlowski JP, Erenberg G, Lueders H, Cruse RP. Hypothermia and barbiturate coma for refractory status epilepticus. Crit Care Med 1984;12:367–372.
Winston KR, Levisohn P, Miller BR, Freeman J. Vagal nerve stimulation for status epilepticus. Pediatr Neurosurg 2001;34:190–192.
Claassen J, Hirsch LJ, Emerson RG, Mayer SA. Treatment of refractory status epilepticus with pentobarbital, propofol, or midazolam: a systematic review. Epilepsia 2002;43:146–153.
Bleck TP. Management approaches to prolonged seizures and status epilepticus. Epilepsia 1999;40(suppl 1):S59–63.
Bleck TP. Refractory status epilepticus in 2001. Arch Neurol 2002;59:188–189.
Sahin M, Riviello JJ Jr. Prolonged treatment of refractory status epilepticus in a child. J Child Neurol 2001;16:147–150.
Krishnamurthy KB, Drislane FW: Relapse and survival after barbiturate anesthetic treatment of refractory status epilepticus. Epilepsia 1996;37:863–867.
Krishnamurthy KB, Drislane FW. Depth of EEG suppression and outcome in barbiturate anesthetic treatment for refractory status epilepticus. Epilepsia 1999;40:759–762.
Sahin M, Menache CC, Holmes GL, Riviello JJ. Outcome of acute symptomatic refractory status epilepticus in children. Neurology 2003;61:398–401.
Mirski MA, Williams MA, Hanley DF. Prolonged pentobarbital and phenobarbital coma for refractory generalized status epileptics. Crit Care Med 1995;23:400–404.
Ohori N, Fujioka Y, Ohta M. Experience in managing refractory status epilepticus caused by viral encephalitis under long-term anesthesia with barbiturate: a case report. Rinsho Shinkeigaku 1998;38:474–477.
Alldredge BK, Wall DB, Ferriero DM. Effect on pre-hospital treatment of status epilepticus in childhood. Ped Neurol 1995;12:213–216.
Yager JY, Seshia SS. Sublingual lorazepam in childhood serial seizures. Am J Dis Child 1988;142:931–932.
Holmes GL. Buccal route for benzodiazepines in treatment of seizures. Lancet 1999;353:608–609.
Scott RC, Besag FM, Neville BG. Buccal midazolam and rectal diazepam for treatment of prolonged seizures in childhood and adolescence: a randomized trial. Lancet 1999;20:623–626.
Lahat E, Goldman M, Barr J, Bistritzer T, Berkovitch. Comparison of intranasal midazolam with intravenous diazepam for treating febrile seizures in children: prospective randomized study. BMJ 2000;321:83–86.
Riviello JJ. Epileptic and epileptiform encephalopathies. Neurology, Emedicine, Boston, 2001. http://www.emedicine.com/neuro/topic547.htm.
Patry G, Lyagoubi S, Tassinari A. Subclinical “electrical status epilepticus” induced by sleep in children. A clinical and electroencephalographic study of six cases. Arch Neurol 1971;24:242–252
Tassinari CA, Bureau M, Dravet C, Dalla Bernardina B, Roger J. Epilepsy with continuous spikes and waves during slow sleep-otherwise described as ESES (epilepsy with electrical status epilepticus during slow sleep. In: Roger J, Bureau M, Dravet C, Dreifuss FE, Perret A, Wolf P, eds. Epileptic Syndromes in Infancy, Childhood, and Adolescencence(2nd ed.). London: John Libbey and Co.; 1992:245–256.
Landau W, Kleffner FR. Syndrome of acquired aphasia with convulsive disorder in children. Neurology 1957;7:523–530.
De Negri M, Baglietto MG, Battaglia FM. Treatment of electrical status epilepticus by short diazepam (DZP) cycles after DZP rectal bolus test. Brain Dev 1995;17:330–333.
Riviello JJ, Holder DL, Thiele E, Bourgeois BFD, Bergin AM, Duffy FH, Holmes GL. Treatment of continuous spikes and waves during slow wave sleep with high dose diazepam. Epilepsia 2001;42(suppl 7):56.
Lerman P, Lerman-Sagie T, Kivity S. Effect of early corticosteroid therapy for Landau-Kleffner Syndrome. Dev Med Child Neurology 1991;33:257–260.
Fayad MN, Choueiri R, Mikati M. Landau-Kleffner syndrome: consistent response to repeated intravenous gamma-globulin doses: a case report. Epilepsia 1997;38:489–494.
Kramer U, Nevo Y, Neufeld MY, Fatal A, Leitner Y, Harel S. Epidemiology of epilepsy in childhood: a cohort of 440 consecutive patients. Ped Neurol 1998;18:46–50.
Bishop DVM. Age of onset and outcome in acquired aphasia with convulsive disorder (Landau-Kleffner Syndrome). Dev Med Child Neurology 1985;27:705–712.
Connolly AM, Chez MG, Pestronk A, Arnold ST, Mehta S, Deuel RK. Serum autoantibodies to brain in Landau-Kleffner variant, autism, and other neurologic disorders. J Pediatr 1999;134:607–613.
Bolanos A, Mikati M, Holmes G, Helmers S, Riviello J. Landau-Kleffner syndrome: clinical and EEG features. Neurology 1995;45(suppl 4):A180.
Bolanos A, Urion DK, Helmers SL, Lombroso CT, Mikati M, Duffy FH, Holmes GL, Riviello J. Serial electroencephalographic changes in children with Landau-Kleffner syndrome. Epilepsia 1997;38(suppl. 3):27.
Holmes GL, McKeever M, Saunders Z. Epileptiform activity in aphasia of childhood: an epiphenomenon? Epilepsia 1981;22:631–639.
Stefanatos GA, Foley C, Grover W, Doherty B. Steady-state auditory evoked responses to pulsed frequency modulations in children. Electroencephalogr Clin Neurophysiol 1997;104:31–42.
Deuel RK, Lenn NJ. Treatment of acquired epileptic aphasia. J Pediatr 1977;90:959–961.
Silver JM, Shin C, McNamara JO. Antiepileptogenic effects of conventional anticonvulsants in the kindling model of epilepsy. Ann Neurol 1991;29:356–363.
Snead OC 3rd, Hosey LC. Exacerbation of seizures in children by carbamazepine. N Engl J Med 1985;313:916–921.
Kochen S, Giagante B, Oddo S. Spike-and-wave complexes and seizure exacerbation caused by carbamazepine. Eur J Neurol 2002;9:41–47.
Gansaeuer M, Alsaadi TM. Carbamazepine-induced seizures: a case report and review of the literature. Clin Electroencephalogr 2002;33:174–177.
Akman CI, Holmes GL. The effect of lamotrigine on the EEGs of children and adolescents with epilepsy. Epilepsy Behav 2003;4:420–423.
Mantovani JF, Landau WM. Acquired aphasia with convulsive disorder: course and prognosis. Neurology 1980;30:524–529.
Deonna T-W, Roulet E, Fontan D, Marcoz J-P. Speech and oromotor deficits of epileptic origin in benign partial epilepsy of childhood with Rolandic spikes (BPERS). Neuropediatrics 1993;24:83–87.
Soprano AM, Garcia EF, Caraballo R, Fejerman N. Acquired epileptic aphasia: neuropsychologic follow-up of 12 patients. Pediatr Neurol 1994;11:230–235.
Veggiotti P, Beccaria F, Guerrini R, Capovilla G, Lanzi G. Continuous spike-and-wave activity during slow-wave sleep: syndrome or EEG pattern? Epilepsia 1999;40:1593–1601.
Guilhoto LMFF, Morrell F. Electrophysiological differences between Landau-Kleffner syndrome and other conditions showing the CSWS electrical pattern. Epilepsia 1994;35(suppl. 8):126.
Marescaux C, Finck S, Maquet P, Schlumberger E, Sellal F, Metz-Lutz MN, Alembik Y, Salmon E, Franck G, Kurtz D. Landau-Kleffner Syndrome: A pharmacologic study of five cases. Epilepsia 1990;31:768–777.
McKinney W, McGreal DA. An aphasic syndrome in children. Can Med J 1974;110:637–639.
Albaradie RS, Bourgeois BFD, Thiele E, Duffy FH, Holmes GL, Riviello JJ. Treatment of continuous spike and wave during slow wave sleep Epilepsia 2001;42(suppl 7):46–47.
Mtchedlishvili Z, Kapur J. A presynaptic action of the neurosteroid pregnenolone sulfate on GABAergic synaptic transmission. Mol Pharmacol 2003;64:857–864
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2005 Humana Press Inc., Totowa, NJ
About this chapter
Cite this chapter
Riviello, J.J. (2005). Status Epilepticus in Children. In: Drislane, F.W. (eds) Status Epilepticus. Current Clinical Neurology. Humana Press. https://doi.org/10.1385/1-59259-945-1:313
Download citation
DOI: https://doi.org/10.1385/1-59259-945-1:313
Publisher Name: Humana Press
Print ISBN: 978-1-58829-355-8
Online ISBN: 978-1-59259-945-5
eBook Packages: MedicineMedicine (R0)